Status:
RECRUITING
COPD Care Pathway Among Patients With Cancer
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Chronic Obstructive Pulmonary Disease
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overc...
Detailed Description
Primary Objective: To design a feasible COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barr...
Eligibility Criteria
Inclusion
- The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:
- patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
- provider who currently works at least part-time in a medical oncology clinic or
- provider who works at least part-time to care for patients with known or suspected COPD.
- A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
- Ability to understand and agree to participate on the study as described by the study information sheet.
- Capability of speaking or reading English.
Exclusion
- Severe psychiatric symptoms; unusual social situation; or critical instability that would limit adherence to the study requirements, as determined by the study team.
Key Trial Info
Start Date :
February 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05984680
Start Date
February 27 2025
End Date
March 1 2026
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157